Technical Analysis for BMND - Biomind Labs Inc
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | N/A | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Fell Below 20 DMA | Bearish | 0.00% | |
| Fell Below 50 DMA | Bearish | 0.00% | |
| MACD Bearish Signal Line Cross | Bearish | 0.00% | |
| Calm After Storm | Range Contraction | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Gapped Down | Weakness | 0.00% | |
| Crossed Above 20 DMA | Bullish | -47.46% | |
| Crossed Above 50 DMA | Bullish | -47.46% | |
| MACD Bullish Signal Line Cross | Bullish | -47.46% |
| Alert | Time |
|---|---|
| Lower Bollinger Band Support | about 8 hours ago |
| Down 1 ATR | about 8 hours ago |
| Down 5% | about 8 hours ago |
| Down 3% | about 8 hours ago |
| Down 2% | about 8 hours ago |
Free Daily (Stock) Chart Reading
- Earnings date: Unknown
Biomind Labs Inc Description
Biomind Labs Inc., a biotech research and development company, focuses on developing novel pharmaceutical drugs and nanotech delivery systems for various psychiatric and neurological conditions. The company is developing BMND01, which is in Phase II clinical trials for use in the treatment of depression; and BMND08, a 5-Methoxy-N,N-dimethyltryptamine based candidate that is in Phase II clinical trials for treatment of depression and anxiety in patients with Alzheimer's-type cognitive impairment. It is also developing new and preclinical drug candidates, including BMND02 for treating fibromyalgia, BMND03 for treating addictive disorders, BMND05 for treating chronic pain, BMND06 for treating inflammatory disorders, and BMND07 for treating major depressive disorder. The company is headquartered in Canelones, Uruguay.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Alzheimer's Disease Chronic Pain Pharmaceutical Drugs Depression Fibromyalgia Major Depressive Disorder
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 1.09 |
| 52 Week Low | 0.025 |
| Average Volume | 2,589 |
| 200-Day Moving Average | 0.000 |
| 50-Day Moving Average | 0.520 |
| 20-Day Moving Average | 0.480 |
| 10-Day Moving Average | 0.463 |
| Average True Range | 0.172 |
| RSI (14) | 42.86 |
| ADX | 10.11 |
| +DI | 34.276 |
| -DI | 30.137 |
| Chandelier Exit (Long, 3 ATRs) | 0.156 |
| Chandelier Exit (Short, 3 ATRs) | 0.725 |
| Upper Bollinger Bands | 0.691 |
| Lower Bollinger Band | 0.269 |
| Percent B (%b) | 0.1 |
| BandWidth | 87.995 |
| MACD Line | -0.022 |
| MACD Signal Line | -0.018 |
| MACD Histogram | -0.0044 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.363 | ||||
| Resistance 3 (R3) | 0.357 | 0.333 | 0.354 | ||
| Resistance 2 (R2) | 0.333 | 0.320 | 0.336 | 0.351 | |
| Resistance 1 (R1) | 0.322 | 0.312 | 0.328 | 0.328 | 0.348 |
| Pivot Point | 0.298 | 0.298 | 0.301 | 0.301 | 0.298 |
| Support 1 (S1) | 0.287 | 0.285 | 0.293 | 0.293 | 0.272 |
| Support 2 (S2) | 0.263 | 0.277 | 0.266 | 0.269 | |
| Support 3 (S3) | 0.252 | 0.263 | 0.266 | ||
| Support 4 (S4) | 0.258 |
